Motilal Oswal completed the acquisition of a majority stake in Megafine Pharma for $53m.

Motilal Oswal, a financial services company, completed the acquisition of a majority stake in Megafine Pharma, an export focused company engaged in development, manufacturing, and sale of a diverse range of high-value, low-volume niche for chronic therapies active pharmaceutical ingredients, for $53m.